Anti-fibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders (Protocol)
<p>This is the protocol for a review and there is no abstract. The objectives are as follows:</p><p>To determine the efficacy and safety of anti-fibrinolytics (lysine analogues) in preventing bleeding in patients with haematological disorders.</p>
Príomhchruthaitheoirí: | Wardrop, D, Estcourt, L, Doree, C, Hopewell, S, Brunskill, S, Stanworth, S, Murphy, M |
---|---|
Formáid: | Journal article |
Foilsithe / Cruthaithe: |
Cochrane Collaboration
2016
|
Míreanna comhchosúla
Míreanna comhchosúla
-
Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
de réir: Estcourt, L, et al.
Foilsithe / Cruthaithe: (2016) -
Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological malignancies (Review).
de réir: Wardrop, D, et al.
Foilsithe / Cruthaithe: (2013) -
Pathogen-reduced platelets for the prevention of bleeding (protocol)
de réir: Butler, C, et al.
Foilsithe / Cruthaithe: (2011) -
Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.
de réir: Estcourt, L, et al.
Foilsithe / Cruthaithe: (2012) -
Different doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation
de réir: Estcourt, L, et al.
Foilsithe / Cruthaithe: (2014)